Saudi Arabia · UAE · GCC

Middle East Pharma Market Entry

Launch your pharmaceutical, biotech or medtech brand in Saudi Arabia, the UAE and the wider GCC with a commercial plan built for the region: the right positioning, compliant omnichannel engagement with healthcare professionals, and content in Arabic and English.

  • Ex-Pfizer · J&J · AbbViePharma marketing and product launches
  • EMEA emerging marketsMarketing experience at Johnson & Johnson
  • Arabic & EnglishStrategy, content and reporting in both
  • Vision 2030 speakerAI & Enterprise Summit
Dr. Mohammad Alsaadany

What it takes

What a successful launch in the Gulf needs.

Pharma marketing in Saudi Arabia and the GCC rewards companies that localize early, engage healthcare professionals across channels and lead with compliance. Global playbooks rarely work unchanged.

  • REG

    A regulatory-first launch

    Content approval workflows that meet Ministry of Health guidelines, clear product information and consent-driven data capture for patient and professional engagement.

    • Approvals
    • Disclaimers
    • Consent
  • HCP

    Omnichannel HCP engagement

    Doctors and pharmacists expect email, WhatsApp, webinars and in-person visits to work together, with educational portals in Arabic and English.

    • Omnichannel
    • HCP portals
    • Webinars
  • KOL

    Trusted local voices

    Respected regional physicians and key opinion leaders carry more weight than advertising, so launch plans need them from day one.

    • KOLs
    • Medical education
    • Community
  • LOC

    Culturally aligned content

    The region’s Arabic-, English- and Urdu-speaking audiences need localized messaging and visuals, not translated global assets.

    • Localization
    • Arabic
    • Visuals
  • DATA

    Data-driven personalization

    Campaigns segmented by specialty and interest, with real-time engagement tracking to refine outreach as the launch unfolds.

    • Segmentation
    • Tracking
    • AI
  • TRUST

    Privacy and trust

    Secure platforms and transparent data use are now a differentiator with patients and healthcare professionals alike.

    • Privacy
    • Security
    • Transparency

How I help you enter

From market assessment to a scaled launch.

  1. 01

    Market and stakeholder assessment

    Map the opportunity, competitors, channels and key stakeholders with market research and real-world insights.

  2. 02

    Positioning and launch plan

    A localized value story, KOL and HCP engagement plan, channel mix and budget for launch and the first year.

  3. 03

    Compliant omnichannel launch

    Campaigns, HCP portals and content in Arabic and English, built with approval workflows from the start.

  4. 04

    Measure and scale

    Dashboards that show what drives demand, then optimization and expansion across the GCC.

Who it’s for

Built for companies entering the Gulf.

Pharma & biotech

Launching a product in the region

Bringing a new product or an existing portfolio to Saudi Arabia, the UAE or the wider GCC.

Medtech & diagnostics

Entering hospitals, clinics and labs

Markets where relationships and education drive adoption, and where diagnostics networks can run to hundreds of clinics.

Investors & consultancies

Testing a market or a deal thesis

Industry expertise on Middle East healthcare and pharma, including through GLG, AlphaSights, Guidepoint and Dialectica.

What leaders say

Trusted by healthcare leaders across the region.

Mohammad is a connector of connectors and seeks to create communities of learning and sharing best practice. I am inspired by his commitment to excellence and in growing a knowledge base in health care and biopharma for the benefit of patients in the Middle East.

Jennifer Cain BirkmoseVP, Global Head of Patient Access and Community Engagement · Roche

Mohammad is a professional, ambitious and smart team player, and a highly competent, talented leader for the business, the product, the company and the team. I wholeheartedly recommend him to anyone who needs to align their business to a higher purpose, get closer to clients and build a business development vision.

Hany MostafaMedical Affairs Leader, Regional Medical Strategy

Mohammad is an exceptional professional with tremendous industry knowledge and experience in the pharmaceutical industry. Working with him has been an absolute pleasure: his expertise, professionalism, and communication methods provided strong deliverables and helped us successfully complete our common project. If you get the opportunity to work with him, do not miss out.

Konstantinos PantelidisHead of Technology, Alma Economics

Mohammad has a large scale of experience and capabilities. His commitment and accountability are a driving force for growth, and he is able to strategically manage challenging situations.

Raghda MohamedGlobal Patient Access & Safety Lead

FAQ

Questions about entering the Middle East.

Which markets do you cover?

Saudi Arabia, the United Arab Emirates, Kuwait and the wider GCC. I work in Arabic and English.

Do you handle product registration?

Registration with regulators such as the Saudi Food and Drug Authority (SFDA) is handled by your regulatory affairs team or local partner. I work alongside them on the commercial side: market assessment, positioning, launch planning, HCP engagement and compliant marketing.

Why is Saudi Arabia a priority market?

Saudi Arabia’s Vision 2030 program is creating a supportive environment for healthcare investment and digital health innovation, and Saudi patients increasingly research health online and on social platforms.

Can you support companies from the US, Europe and Canada?

Yes. I work remotely with companies in North America and Europe, and schedule calls to suit your time zone.

How do we start?

Book a strategy call or take the free 12-question assessment. We review your goals and the market, then agree a plan and scope.

Free assessment Book a call